TrialHaemophilia : the official journal of the World Federation of Hemophilia2008

A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease.

M V Ragni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.